RT Journal Article
SR Electronic
T1 Prospective Observational Study of Screening Asymptomatic Healthcare Workers for SARS-CoV-2 at a Canadian Tertiary Care Center
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.07.21.20159053
DO 10.1101/2020.07.21.20159053
A1 Kumar, Deepali
A1 Ferreira, Victor H.
A1 Chruscinski, Andrzej
A1 Kulasingam, Vathany
A1 Pugh, Trevor J.
A1 Dus, Tamara
A1 Wouters, Brad
A1 Oza, Amit
A1 Ierullo, Matthew
A1 Ku, Terrance
A1 Majchrzak-Kita, Beata
A1 Humar, Sonika T.
A1 Bahinskaya, Ilona
A1 Pinzon, Natalia
A1 Zhang, Jianhua
A1 Heisler, Lawrence E.
A1 Krzyzanowski, Paul M.
A1 Lam, Bernard
A1 Lungu, Ilinca M.
A1 Manase, Dorin
A1 Pace, Krista M.
A1 Mashouri, Pouria
A1 Brudno, Michael
A1 Garrels, Michael
A1 Mazzulli, Tony
A1 Cybulsky, Myron
A1 Humar, Atul
YR 2020
UL http://medrxiv.org/content/early/2020/07/28/2020.07.21.20159053.abstract
AB We screened three separate cohorts of healthcare workers for SARS-CoV-2 via nasopharyngeal swab PCR. A seroprevalence analysis using multiple assays was performed in a subgroup. The asymptomatic health care worker cohorts had a combined swap positivity rate of 29/5776 (0.50%, 95%CI 0.32-0.75) compared to the symptomatic cohort rate of 54/1597 (3.4%) (ratio of symptomatic to asymptomatic 6.8:1). Sequencing demonstrated several variants. The seroprevalence (n=996) was 1.4-3.4% depending on assay. Protein microarray analysis showed differing SARS-CoV-2 protein reactivities and helped define likely true positives vs. suspected false positives. Routine screening of asymptomatic health care workers helps identify a significant proportion of infections.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThis was not a clinical trial. No interventions took place.Funding StatementThe study was funded by the Mount Sinai Hospital and University Health Network Academic Medical Organization. It was also funded by the Toronto General and Western Foundation. No author or institution received payment or services from a third party for any aspect of the submitted work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the University Health Network Research Ethics Board.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesStudy data are available upon request.